ANGO - Here's Why This Hidden Growth Stock Is a Buy
As a growth investor, the key to building wealth is to buy decent companies in industries with compelling growth stories and hold for the long haul.
Due to the launch of new and advanced medical devices to fill unmet needs, few industries will be able to match the growth of the medical devices industry moving forward. This is why the market research firm Precedence Research anticipates that the global medical devices market will compound at 5.5% each year from $550 billion in 2021 to $850 billion in 2030.
In such a vast industry, there's plenty of room for smaller companies to thrive alongside the more established players. With a $545 million market capitalization , the peripheral vascular disease and cancer treatment medical device maker AngioDynamics (NASDAQ: ANGO) looks like it could do well in the years to come. Here are three reasons why.
For further details see:
Here's Why This Hidden Growth Stock Is a Buy